HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tyson Lee Selected Research

pamrevlumab

8/2010Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tyson Lee Research Topics

Disease

2Hypoxia (Hypoxemia)
01/2016 - 10/2015
2Anemia
01/2016 - 10/2015
1Chronic Renal Insufficiency
10/2015
1Proteinuria
08/2010
1Albuminuria
08/2010
1Diabetic Nephropathies (Diabetic Nephropathy)
08/2010

Drug/Important Bio-Agent (IBA)

2roxadustatIBA
01/2016 - 10/2015
2Prolyl-Hydroxylase InhibitorsIBA
01/2016 - 10/2015
1IronIBA
01/2016
1Hemoglobins (Hemoglobin)IBA
01/2016
1HepcidinsIBA
01/2016
1pamrevlumabIBA
08/2010
1Proteins (Proteins, Gene)FDA Link
08/2010
1Therapeutic UsesIBA
08/2010
1Connective Tissue Growth FactorIBA
08/2010
1Monoclonal AntibodiesIBA
08/2010